Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Unopposed Production of Granulocyte-Macrophage Colony-Stimulating Factor by Tumors Inhibits CD8+ T Cell Responses by Dysregulating Antigen-Presenting Cell Maturation
1999
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope
1990
Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
1996
Workup and management of patients with syncope
1995
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures
1995
Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.
1993
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION
1989
Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator
1999
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Randomized Clinical Trials of Neurally Mediated Syncope
2003
Hematopoietic Growth Factors
1989
PET and [18F]-FDG in oncology: A clinical update
1996
The colony stimulating factors discovery, development, and clinical applications
1990
The generation of diversity and pattern in animal development
1992 StandoutNobel
CLINICAL IMPLICATIONS OF ELECTROPHYSIOLOGY STUDY FINDINGS IN PATIENTS WITH CHRONIC BIFASCICULAR BLOCK AND SYNCOPE
1988
Safety and Convenience of Continuous Warfarin Strategy During the Periprocedural Period in Patients Who Underwent Catheter Ablation of Atrial Fibrillation
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
1996 Standout
The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells
1989 StandoutNature
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
1991 StandoutNature
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy.
1992
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome
1998
Interleukin-2 toxicity.
1991
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
1996
University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia
1991 StandoutNobel
Syncope of unknown origin: Clinical, noninvasive, and electrophysiologic determinants of arrhythmia induction and symptom recurrence during long-term follow-up
1991
Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy
1995
Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia
1990
Graft-versus-host disease
2009 Standout
The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
1992 StandoutNobel
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation
2001
The control of growth and differentiation in normal and leukemic blood cells
1990
GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN
1988
Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL
1996 Standout
Is syncope a risk factor for poor outcomes? comparison of patients with and without syncope
1996
Radiofrequency Catheter Modification of Atrioventricular Conduction to Control the Ventricular Rate during Atrial Fibrillation
1994
Sudden cardiac death and polymorphous ventricular tachycardia in pationts with normal QT intervals and normal systolic cardiac function
1995
Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.
1989
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
1993
A review of autologous hematopoietic cell transplantation
2000 Nobel
Incidence and Prognosis of Syncope
2002 Standout
Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantablecardioverter defibrillator therapy
2003
Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin
1988
Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro.
1990
Bundle Branch Reentrant Ventricular Tachycardia:
1993
Comparison of Cardiac Pacing with Drug Therapy in the Treatment of Neurocardiogenic (Vasovagal) Syncope with Bradycardia or Asystole
1993
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
1999 Standout
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
1998 Standout
Guidelines on management (diagnosis and treatment) of syncope
2001
Natural history of patients with unexplained syncope and a nondiagnostic electrophysiologic study
1989
Use of the Implantable Loop Recorder in Evaluation of Patients with Unexplained Syncope
2003
Neutropenia: Antibiotic combinations for empiric therapy
1989
Cancer of the Ovary
2004 Standout
The value of electrophysiologic studies in syncope of undetermined origin: Report of 150 cases
1985
Electrophysiologic testing in bundle branch block and unexplained syncope
1984
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Role of electrophysiologic testing in the diagnosis and treatment of patients with known and suspected bradycardias and tachycardias
1981
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Significance of inducible tachycardia in patients with syncope of unknown origin: A long-term follow-up
1985
Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery
1995
Tilt table testing for assessing syncope
1996
Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure
1998 Standout
Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin.
1988
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Brugada Syndrome: Report of the Second Consensus Conference
2005 Standout
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel
Impact of Atrial Fibrillation on the Risk of Death
1998 Standout
Sudden Cardiac Death
1998 Standout
Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations
1996
Different stromal cell lines support lineage-selective differentiation of the multipotential bone marrow stem cell clone LyD9.
1991 StandoutNobel
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Gene correction in hematopoietic progenitor cells by homologous recombination
2000 StandoutNobel
Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation.
1994
Aortocoronary Saphenous Vein Graft Disease
1998 Standout
Structural design and molecular evolution of a cytokine receptor superfamily.
1990 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Electrophysiologic testing in patients with unexplained syncope: Clinical and noninvasive predictors of outcome
1987
Growth Factors and Cancer
1991 StandoutScience
CLINICAL GUIDELINE: Diagnosing Syncope: Part 2: Unexplained Syncope
1997
Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.
1991
Premature expression of the macrophage colony-stimulating factor receptor on a multipotential stem cell line does not alter differentiation lineages controlled by stromal cells used for coculture.
1991 StandoutNobel
The distinct surface of human blood dendritic cells, as observed after an improved isolation method.
1990 StandoutNobel
A controlled trial of recombinant human granulocyte-macrophage colony- stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma
1992
A Prospective Evaluation and Follow-up of Patients with Syncope
1983 Standout
Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope
1985
Angiogenesis.
1992 Standout
Works of C J Gilbert being referenced
Periprocedural Anticoagulation for Atrial Fibrillation Ablation
2008
Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation
1988
Unexplained Syncope Evaluated by Electrophysiologic Studies and Head-up Tilt Testing
1991
Retrograde conduction in the His-Purkinje system. Analysis of the routes of impulse propagation using His and right bundle branch recordings.
1979
Electrophysiologic mechanisms for modification and abolition of atrioventricular junctional tachycardia with simultaneous and sequential atrial and ventricular pacing.
1979
Effects of alternating cycle lengths on refractoriness of the His-Purkinje system.
1984
Selective transcatheter ablation of the fast and slow pathways using radiofrequency energy in patients with atrioventricular nodal reentrant tachycardia.
1992
Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length
1984
Role of Cardiac Electrophysiologic Studies in Patients with Unexplained Recurrent Syncope
1983
Effect of lidocaine on atrioventricular response via the accessory pathway in patients with Wolff-Parkinson-White syndrome.
1981
Demonstration of intra-atrial conduction delay, block, gap and reentry: a report of two cases.
1978
Effects of abrupt changes in cycle length on refractoriness of the His-Purkinje system in man.
1983
Atrioventricular nodal conduction and refractoriness after intranodal collision from antegrade and retrograde impulses.
1983
Facilitation of macroreentry within the His-Purkinje system with abrupt changes in cycle length.
1984